{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:03:37Z","timestamp":1742403817244},"reference-count":19,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3892\/ol.2016.4631","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T07:12:25Z","timestamp":1464246745000},"page":"485-487","source":"Crossref","is-referenced-by-count":8,"title":["Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up"],"prefix":"10.3892","volume":"12","author":[{"given":"KATIA BORGIA BARBOSA","family":"PAGNANO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00c1RCIA TORRESAN","family":"DELAMAIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARIANA MUNARI","family":"MAGNUS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOS\u00c9","family":"VASSALLO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CARMINO ANTONIO","family":"DE SOUZA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAIANE","family":"DE ALMEIDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IRENE","family":"LORAND-METZE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"key20180108111811_b1-ol-0-0-4631","first-page":"23","volume":"2","author":"Swerdlow","year":"2008","journal-title":"WHO Classification of Tumors of Haematopoietics and Lymphoid Tissues"},{"key":"key20180108111811_b2-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Cancer Genome Project: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"key20180108111811_b3-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/S1415-47572007000300006","article-title":"JAK V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia","volume":"30","author":"Monte-M\u00f3r","year":"2007","journal-title":"Genet Mol Biol"},{"key":"key20180108111811_b4-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"key20180108111811_b5-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"key20180108111811_b6-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.leukres.2009.09.025","article-title":"A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm","volume":"34","author":"V\u00e9ron\u00e8se","year":"2010","journal-title":"Leuk Res"},{"key":"key20180108111811_b7-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12185-008-0131-2","article-title":"Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia","volume":"88","author":"Conchon","year":"2008","journal-title":"Int J Hematol"},{"key":"key20180108111811_b8-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12185-009-0471-6","article-title":"A man with concomitant polycythaemia vera and chronic myeloid leukemia: The dynamics of the two disorders","volume":"91","author":"Bee","year":"2010","journal-title":"Int J Hematol"},{"key":"key20180108111811_b9-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2011-07-365007","article-title":"Concomitant occurrence of BCR-ABL and JAK2V617F mutation","volume":"118","author":"Pieri","year":"2011","journal-title":"Blood"},{"key":"key20180108111811_b10-ol-0-0-4631","first-page":"186","article-title":"(1994) An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders","volume":"8","author":"Cross","year":"1994","journal-title":"Leukemia"},{"key":"key20180108111811_b11-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/leu.2012.104","article-title":"Standardized definitions of molecular response in chronic myeloid leukemia","volume":"26","author":"Cross","year":"2012","journal-title":"Leukemia"},{"key":"key20180108111811_b12-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000430835","article-title":"BCR-ABL1 transcript levels at 3 and 6 months are better for identifying chronic myeloid leukemia patients with poor outcome in response to second-line second-generation tyrosine kinase inhibitors after imatinib failure: A report from a single institution","volume":"134","author":"Ribeiro","year":"2015","journal-title":"Acta Haematol"},{"key":"key20180108111811_b13-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.leukres.2008.03.004","article-title":"Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2 V617F-positive chronic idiopathic myelofibrosis","volume":"32","author":"Jallades","year":"2008","journal-title":"Leuk Res"},{"key":"key20180108111811_b14-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.3816\/CLM.2009.n.080","article-title":"Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2 V617F as a potential risk factor for BCR-ABL translocation","volume":"9","author":"Pingali","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"key20180108111811_b15-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s12032-010-9570-8","article-title":"Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera","volume":"28","author":"Toogeh","year":"2011","journal-title":"Med Oncol"},{"key":"key20180108111811_b16-ol-0-0-4631","first-page":"34","article-title":"The concomitant occurrence of JAK2 V617F mutation and BCR\/ABL transcript with phenotypic expression - an overlapping myeloproliferative disorder or two distinct diseases? - case report","volume":"6","author":"Ursuleac","year":"2013","journal-title":"J Med Life"},{"key":"key20180108111811_b17-ol-0-0-4631","first-page":"169","article-title":"JAK2 V617F mutation evaluation of chronic myeloid leukemia and acute myeloid leukemia","volume":"31","author":"Pagnano","year":"2009","journal-title":"Rev Bras Hematol Hemoter"},{"key":"key20180108111811_b18-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1034\/j.1600-0609.2003.00043.x","article-title":"Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia","volume":"70","author":"Wahlin","year":"2003","journal-title":"Eur J Haematol"},{"key":"key20180108111811_b19-ol-0-0-4631","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12185-010-0502-3","article-title":"Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia","volume":"91","author":"Mizutani","year":"2010","journal-title":"Int J Hematol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4631\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T15:15:31Z","timestamp":1515424531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,26]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.3892\/ol.2016.4631"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4631","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]}}}